Showing 1 - 7 results of 7 for search 'Roberto Murialdo', query time: 0.03s Refine Results
  1. 1
    Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.

    Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma. by Lorenzo Ferrando, Gabriella Cirmena, Anna Garuti, Stefano Scabini, Federica Grillo, Luca Mastracci, Edoardo Isnaldi, Ciro Marrone, Roberta Gonella, Roberto Murialdo, Roberto Fiocca, Emanuele Romairone, Alberto Ballestrero, Gabriele Zoppoli

    Published 2020-01-01
    Get full text
    Article
  2. 2
    The Multidisciplinary Approach of Rectal Cancer: The Experience of “COMRE Group” Model

    The Multidisciplinary Approach of Rectal Cancer: The Experience of “COMRE Group” Model by Stefano Scabini, Emanuele Romairone, Davide Pertile, Andrea Massobrio, Alessandra Aprile, Luca Tagliafico, Domenico Soriero, Luca Mastracci, Federica Grillo, Almalina Bacigalupo, Ciro Marrone, Maria Caterina Parodi, Marina Sartini, Maria Luisa Cristina, Roberto Murialdo, Gabriele Zoppoli, Alberto Ballestrero

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases

    Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases by Gabriele Zoppoli, Anna Garuti, Gabriella Cirmena, Ludovica Verdun di Cantogno, Cristina Botta, Maurizio Gallo, Domenico Ferraioli, Enrico Carminati, Paola Baccini, Monica Curto, Piero Fregatti, Edoardo Isnaldi, Michela Lia, Roberto Murialdo, Daniele Friedman, Anna Sapino, Alberto Ballestrero

    Published 2017-05-01
    Get full text
    Article
  4. 4
    Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer

    Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer by Edoardo Isnaldi, Anna Garuti, Gabriella Cirmena, Stefano Scabini, Edoardo Rimini, Lorenzo Ferrando, Michela Lia, Roberto Murialdo, Lucia Tixi, Enrico Carminati, Andrea Panaro, Maurizio Gallo, Federica Grillo, Luca Mastracci, Lazzaro Repetto, Roberto Fiocca, Emanuele Romairone, Gabriele Zoppoli, Alberto Ballestrero

    Published 2019-04-01
    Get full text
    Article
  5. 5
    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study

    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study by Francesco Ravera, Roberto Borea, Gabriella Cirmena, Martina Dameri, Lorenzo Ferrando, Maurizio Gallo, Cecilia Casini, Neri Fallani, Mario Stabile, Valentina Barbero, Roberto Murialdo, Lucia Tixi, Margherita Cappuccio, Andrea Cuboni, Irene Sivieri, Giuseppe Fornarini, Andrea De Maria, Alberto Ballestrero, Gabriele Zoppoli

    Published 2022-05-01
    Get full text
    Article
  6. 6
    Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment

    Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment by Francesca Valdemarin, Irene Caffa, Angelica Persia, Anna Laura Cremonini, Lorenzo Ferrando, Luca Tagliafico, Alberto Tagliafico, Ana Guijarro, Federico Carbone, Stefano Ministrini, Maria Bertolotto, Pamela Becherini, Tommaso Bonfiglio, Chiara Giannotti, Amr Khalifa, Moustafa Ghanem, Michele Cea, Marzia Sucameli, Roberto Murialdo, Valentina Barbero, Raffaella Gradaschi, Francesca Bruzzone, Consuelo Borgarelli, Matteo Lambertini, Claudio Vernieri, Gabriele Zoppoli, Valter D. Longo, Fabrizio Montecucco, Samir G. Sukkar, Alessio Nencioni

    Published 2021-08-01
    Get full text
    Article
  7. 7
    TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

    TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The... by Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni G. Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maio, Lorenzo Fornaro, Giovanni L. Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro, Filippo Pietrantonio

    Published 2021-06-01
    Get full text
    Article

Search Tools: